推荐给爱力根公司(“爱力根”)AbbVie Inc . (“AbbVie”)(“收购”)通过协议安排根据爱尔兰法律(“计划”)。你正试图进入这个网站的部分指定的文档和信息的发布与AbbVie提供的爱力根6月25日宣布,2019年(“提供”)。访问网站的这个部分可能被限制在证券法在某些司法辖区。此通知要求您确认某些事情(包括你不居住在这样一个管辖),之前你可能获得访问信息。信息不是针对,并不打算访问,人居住在任何管辖权,这样做违反了有关法律的管辖。如果你不允许查看信息,或查看信息会导致违反上面,或者你有疑问你是否允许查看信息,请退出本网页。这部分的网站包含公告、文件和信息(“信息”)一起提供符合有关爱尔兰收购委员会法案,1997年收购法规2013(“爱尔兰收购规则”)。信息是在诚信和信息目的,及其可用性是受以下条款和条件。信息并不打算,并不构成或任何形式的一部分,提供出售或以其他方式处置或征集的邀请或要约购买或收购任何证券,或征集投票或批准按照或其他信息。任何人寻求进入本节ABBVIE ABBVIE网站的代表和认股权证,他们这样做有目的的信息。 BASIS OF ACCESS TO INFORMATION Please read this notice carefully before clicking "I agree" or "I disagree" below. This notice applies to all persons who view this section of the website and, depending on where you live, it may affect your rights. This notice may be amended or updated by AbbVie from time to time and it should be read carefully in full each time you wish to view the website. In addition, the content of the website, and its accessibility by certain persons, may be amended at any time in whole or in part at the sole discretion of AbbVie. The Information speaks only at the date of the relevant document or announcement and AbbVie has, and accepts, no responsibility or duty to update any Information (other than to the extent such duty arises as a matter of law or regulation).